| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| Gesamt | 753.321.317 $ | 99,40 | 5.580.496 | ||||||
| Eli Lilly & Co | Eli Lilly & Co | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 94.525.015 $ | 12,47 | 85.543 | |
| AbbVie Inc | AbbVie Inc | EC | 00287Y109 | Long | Börsenkurs (Stufe 1) | 48.924.514 $ | 6,46 | 224.713 | |
| Johnson & Johnson | Johnson & Johnson | EC | 478160104 | Long | Börsenkurs (Stufe 1) | 48.853.347 $ | 6,45 | 216.808 | |
| AstraZeneca PLC | AstraZeneca PLC | EC | GB0009895292 | Long | Modellwert (Stufe 2) | 47.324.009 $ | 6,24 | 254.890 | |
| UnitedHealth Group Inc | UnitedHealth Group Inc | EC | 91324P102 | Long | Börsenkurs (Stufe 1) | 41.586.518 $ | 5,49 | 109.349 | |
| Roche Holding AG | Roche Holding AG | EC | CH1499059983 | Long | Modellwert (Stufe 2) | 41.244.449 $ | 5,44 | 98.026 | |
| Merck & Co Inc | Merck & Co Inc | EC | 58933Y105 | Long | Börsenkurs (Stufe 1) | 38.485.819 $ | 5,08 | 324.173 | |
| Bristol-Myers Squibb Co | Bristol-Myers Squibb Co | EC | 110122108 | Long | Börsenkurs (Stufe 1) | 32.229.736 $ | 4,25 | 563.654 | |
| Vertex Pharmaceuticals Inc | Vertex Pharmaceuticals Inc | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 25.636.881 $ | 3,38 | 57.284 | |
| Gilead Sciences Inc | Gilead Sciences Inc | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 25.323.251 $ | 3,34 | 188.375 | |
| Sanofi SA | Sanofi SA | EC | FR0000120578 | Long | Modellwert (Stufe 2) | 22.338.434 $ | 2,95 | 254.833 | |
| Thermo Fisher Scientific Inc | Thermo Fisher Scientific Inc | EC | 883556102 | Long | Börsenkurs (Stufe 1) | 21.176.945 $ | 2,79 | 42.998 | |
| Intuitive Surgical Inc | Intuitive Surgical Inc | EC | 46120E602 | Long | Börsenkurs (Stufe 1) | 20.586.547 $ | 2,72 | 48.480 | |
| Stryker Corp | Stryker Corp | EC | 863667101 | Long | Börsenkurs (Stufe 1) | 16.764.085 $ | 2,21 | 54.948 | |
| Boston Scientific Corp | Boston Scientific Corp | EC | 101137107 | Long | Börsenkurs (Stufe 1) | 16.495.498 $ | 2,18 | 341.451 | |
| Medtronic PLC | Medtronic PLC | EC | IE00BTN1Y115 | Long | Börsenkurs (Stufe 1) | 13.664.741 $ | 1,80 | 185.134 | |
| Lonza Group AG | Lonza Group AG | EC | CH0013841017 | Long | Modellwert (Stufe 2) | 13.419.336 $ | 1,77 | 21.010 | |
| Novo Nordisk A/S | Novo Nordisk A/S | EC | DK0062498333 | Long | Modellwert (Stufe 2) | 12.955.299 $ | 1,71 | 283.516 | |
| Abbott Laboratories | Abbott Laboratories | EC | 002824100 | Long | Börsenkurs (Stufe 1) | 12.507.187 $ | 1,65 | 146.112 | |
| Novartis AG | Novartis AG | EC | CH0012005267 | Long | Modellwert (Stufe 2) | 12.502.534 $ | 1,65 | 83.123 | |
| Argenx SE | Argenx SE | EC | 04016X101 | Long | Börsenkurs (Stufe 1) | 12.206.290 $ | 1,61 | 14.601 | |
| Royalty Pharma PLC | Royalty Pharma PLC | EC | GB00BMVP7Y09 | Long | Börsenkurs (Stufe 1) | 12.008.362 $ | 1,58 | 215.358 | |
| Neurocrine Biosciences Inc | Neurocrine Biosciences Inc | EC | 64125C109 | Long | Börsenkurs (Stufe 1) | 10.674.169 $ | 1,41 | 67.430 | |
| Mettler-Toledo International Inc | Mettler-Toledo International Inc | EC | 592688105 | Long | Börsenkurs (Stufe 1) | 10.307.644 $ | 1,36 | 8.731 | |
| Straumann Holding AG | Straumann Holding AG | EC | CH1175448666 | Long | Modellwert (Stufe 2) | 10.148.143 $ | 1,34 | 83.976 | |
| Quest Diagnostics Inc | Quest Diagnostics Inc | EC | 74834L100 | Long | Börsenkurs (Stufe 1) | 9.825.299 $ | 1,30 | 50.412 | |
| Genmab A/S | Genmab A/S | EC | DK0010272202 | Long | Modellwert (Stufe 2) | 9.060.303 $ | 1,20 | 34.565 | |
| Edwards Lifesciences Corp | Edwards Lifesciences Corp | EC | 28176E108 | Long | Börsenkurs (Stufe 1) | 8.867.326 $ | 1,17 | 102.548 | |
| Zoetis Inc | Zoetis Inc | EC | 98978V103 | Long | Börsenkurs (Stufe 1) | 8.496.334 $ | 1,12 | 109.362 | |
| Cooper Cos Inc/The | Cooper Cos Inc/The | EC | 216648501 | Long | Börsenkurs (Stufe 1) | 7.848.407 $ | 1,04 | 128.221 | |
| CSL Ltd | CSL Ltd | EC | AU000000CSL8 | Long | Modellwert (Stufe 2) | 6.880.596 $ | 0,91 | 99.071 | |
| HeartFlow Inc | HeartFlow Inc | EC | 42238D107 | Long | Börsenkurs (Stufe 1) | 6.783.938 $ | 0,90 | 218.978 | |
| Danaher Corp | Danaher Corp | EC | 235851102 | Long | Börsenkurs (Stufe 1) | 6.768.289 $ | 0,89 | 37.052 | |
| Recordati Industria Chimica e Farmaceutica SpA | Recordati Industria Chimica e Farmaceutica SpA | EC | IT0003828271 | Long | Modellwert (Stufe 2) | 5.505.212 $ | 0,73 | 91.672 | |
| Xenon Pharmaceuticals Inc | Xenon Pharmaceuticals Inc | EC | 98420N105 | Long | Börsenkurs (Stufe 1) | 5.481.155 $ | 0,72 | 100.149 | |
| Generate Biomedicines Inc | Generate Biomedicines Inc | EC | 370920100 | Long | Börsenkurs (Stufe 1) | 4.100.000 $ | 0,54 | 312.500 | |
| Apogee Therapeutics Inc | Apogee Therapeutics Inc | EC | 03770N101 | Long | Börsenkurs (Stufe 1) | 2.764.422 $ | 0,36 | 33.655 | |
| Newamsterdam Pharma Co NV | Newamsterdam Pharma Co NV | EC | NL00150012L7 | Long | Börsenkurs (Stufe 1) | 2.750.039 $ | 0,36 | 81.652 | |
| Caris Life Sciences Inc | Caris Life Sciences Inc | EC | 142152107 | Long | Börsenkurs (Stufe 1) | 2.270.693 $ | 0,30 | 135.807 | |
| EssilorLuxottica SA | EssilorLuxottica SA | EC | FR0000121667 | Long | Modellwert (Stufe 2) | 2.152.169 $ | 0,28 | 10.648 | |
| MBX Biosciences Inc | MBX Biosciences Inc | EC | 55287L101 | Long | Börsenkurs (Stufe 1) | 1.878.381 $ | 0,25 | 59.688 | |
| Gesamt | 753.321.317 $ | 99,40 | 5.580.496 |